查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434998

愛迪生氏症症藥物市場：按藥物類別、診斷、治療方法、分銷管道、給藥途徑分類 - 全球預測 2024-2030

Addison's Disease Treatment Market by Drug Class (Glucocorticoid, Mineralocorticoid), Diagnosis (Imaging Testing, Laboratory Testing), Treatments, Distribution Channel, Route of Administration - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

愛迪生氏症治療市場規模預計2023年為14.1億美元，預計2024年將達到15.4億美元，2030年將達到28.8億美元，複合年成長率為10.72%。

愛迪生氏症病藥物的全球市場

主要市場統計
基準年[2023] 14.1億美元
預測年份 [2024] 15.4億美元
預測年份 [2030] 28.8億美元
複合年成長率（%） 10.72%
艾迪生氏症治療藥物Market-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估愛迪生氏症藥物市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對愛迪生氏症治療藥物市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-愛迪生氏症治療藥物市場的市場規模和預測是多少？

2-在愛迪生氏症治療藥物市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-愛迪生氏症治療藥物市場的技術趨勢和法律規範是什麼？

4-愛迪生氏症治療藥物市場主要供應商的市場佔有率是多少？

5-進入愛迪生氏症藥物市場的適當型態或策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球愛迪生氏症率增加
      • 人們對腎上腺功能不全的認知不斷增強
      • 實施強大的醫療基礎設施和有利的報銷政策
    • 抑制因素
      • 艾迪生治療相關的高成本
    • 機會
      • 對新一代技術整合先進療法的需求不斷成長
      • 增加研發活動並提高公司對開發愛迪生氏症治療方法的關注
    • 任務
      • 人們對愛迪生氏症缺乏認知
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章依藥物類別分類的愛迪生氏症治療藥物市場

  • 糖皮質素
    • 地塞米松
    • Hydrocortisone
    • 強的松
  • 鹽皮質激素
    • ludrocortisone

第7章 依診斷分類的愛迪生氏症治療藥物市場

  • 影像檢查
  • 臨床檢查

第8章愛迪生氏症治療藥物市場（依治療）

  • 皮質類固醇注射
  • 自然療法解決方案
  • 口服類固醇

第9章愛迪生氏症治療藥物市場：按分銷管道

  • 電子商務
  • 醫院藥房
  • 零售藥房

第 10 章愛迪生氏症治療藥物市場：依給藥途徑

  • 口服
  • 家長

第11章 美洲愛迪生氏症生病藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區愛迪生氏症治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東和非洲愛迪生氏症症藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第15章競爭組合

  • 主要公司簡介
    • Abbott Laboratories
    • Actiza Pharmaceutical Private Limited
    • Akorn Operating Company LLC
    • Amgen Inc.
    • Amneal Pharmaceuticals, Inc.
    • Bay Biosciences LLC
    • Bayer AG
    • Bio-Techne Corporation
    • Biogen Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • BTL Biotechno Labs Pvt Ltd.
    • Cardinal Health, Inc.
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • Hikma Pharmaceuticals PLC
    • LUMITOS AG
    • Lupin Limited
    • Merck KGaA
    • Neurocrine Biosciences, Inc.
    • Novartis AG
    • Pfizer Inc.
    • Recipharm AB
    • Sandoz International GmbH
    • Takeda Pharmaceutical Company Limited
  • 主要產品系列

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-B16853776F22

[195 Pages Report] The Addison's Disease Treatment Market size was estimated at USD 1.41 billion in 2023 and expected to reach USD 1.54 billion in 2024, at a CAGR 10.72% to reach USD 2.88 billion by 2030.

Global Addison's Disease Treatment Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.41 billion
Estimated Year [2024] USD 1.54 billion
Forecast Year [2030] USD 2.88 billion
CAGR (%) 10.72%
Addison's Disease Treatment Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Addison's Disease Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Addison's Disease Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Addison's Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Actiza Pharmaceutical Private Limited, Akorn Operating Company LLC, Amgen Inc., Amneal Pharmaceuticals, Inc., Bay Biosciences LLC, Bayer AG, Bio-Techne Corporation, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, BTL Biotechno Labs Pvt Ltd., Cardinal Health, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, LUMITOS AG, Lupin Limited, Merck KGaA, Neurocrine Biosciences, Inc., Novartis AG, Pfizer Inc., Recipharm AB, Sandoz International GmbH, and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Addison's Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Class
    • Glucocorticoid
      • Dexamethasone
      • Hydrocortisone
      • Prednisone
    • Mineralocorticoid
      • Fludrocortisone
  • Diagnosis
    • Imaging Testing
    • Laboratory Testing
  • Treatments
    • Corticosteroid Injections
    • Naturopathic Solutions
    • Oral Corticosteroids
  • Distribution Channel
    • E-Commerce
    • Hospital Pharmacy
    • Retail Pharmacy
  • Route of Administration
    • Oral
    • Parental
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Addison's Disease Treatment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Addison's Disease Treatment Market?

3. What are the technology trends and regulatory frameworks in the Addison's Disease Treatment Market?

4. What is the market share of the leading vendors in the Addison's Disease Treatment Market?

5. Which modes and strategic moves are suitable for entering the Addison's Disease Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Addison's Disease Treatment Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of Addison's disease globally
      • 5.1.1.2. Growing awareness regarding adrenal insufficiency
      • 5.1.1.3. Inception of robust healthcare infrastructure and favorable reimbursement policies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with the Addison treatment medications
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for new generation technologically integrated advanced therapeutic drugs
      • 5.1.3.2. Increasing R&D activities and rising focus of the companies in developing treatments for Addison's disease
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness among people regarding Addison's disease
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Addison's Disease Treatment Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Glucocorticoid
    • 6.3.1. Dexamethasone
    • 6.3.2. Hydrocortisone
    • 6.3.3. Prednisone
  • 6.3. Mineralocorticoid
    • 6.4.1. Fludrocortisone

7. Addison's Disease Treatment Market, by Diagnosis

  • 7.1. Introduction
  • 7.2. Imaging Testing
  • 7.3. Laboratory Testing

8. Addison's Disease Treatment Market, by Treatments

  • 8.1. Introduction
  • 8.2. Corticosteroid Injections
  • 8.3. Naturopathic Solutions
  • 8.4. Oral Corticosteroids

9. Addison's Disease Treatment Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. E-Commerce
  • 9.3. Hospital Pharmacy
  • 9.4. Retail Pharmacy

10. Addison's Disease Treatment Market, by Route of Administration

  • 10.1. Introduction
  • 10.2. Oral
  • 10.3. Parental

11. Americas Addison's Disease Treatment Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Addison's Disease Treatment Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Addison's Disease Treatment Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Abbott Laboratories
    • 15.1.2. Actiza Pharmaceutical Private Limited
    • 15.1.3. Akorn Operating Company LLC
    • 15.1.4. Amgen Inc.
    • 15.1.5. Amneal Pharmaceuticals, Inc.
    • 15.1.6. Bay Biosciences LLC
    • 15.1.7. Bayer AG
    • 15.1.8. Bio-Techne Corporation
    • 15.1.9. Biogen Inc.
    • 15.1.10. Boehringer Ingelheim International GmbH
    • 15.1.11. Bristol-Myers Squibb Company
    • 15.1.12. BTL Biotechno Labs Pvt Ltd.
    • 15.1.13. Cardinal Health, Inc.
    • 15.1.14. Eli Lilly and Company
    • 15.1.15. GlaxoSmithKline PLC
    • 15.1.16. Hikma Pharmaceuticals PLC
    • 15.1.17. LUMITOS AG
    • 15.1.18. Lupin Limited
    • 15.1.19. Merck KGaA
    • 15.1.20. Neurocrine Biosciences, Inc.
    • 15.1.21. Novartis AG
    • 15.1.22. Pfizer Inc.
    • 15.1.23. Recipharm AB
    • 15.1.24. Sandoz International GmbH
    • 15.1.25. Takeda Pharmaceutical Company Limited
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ADDISON'S DISEASE TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ADDISON'S DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ADDISON'S DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ADDISON'S DISEASE TREATMENT MARKET DYNAMICS
  • FIGURE 7. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 8. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
  • FIGURE 10. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2023 VS 2030 (%)
  • FIGURE 12. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 16. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. ADDISON'S DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. ADDISON'S DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ADDISON'S DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ADDISON'S DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 6. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 8. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY PREDNISONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 13. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY FLUDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 15. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY IMAGING TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 18. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROID INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY NATUROPATHIC SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ORAL CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY PARENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 145. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 146. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 151. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 152. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 153. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 158. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 159. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 160. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 172. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 173. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 174. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 175. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 180. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 181. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 182. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 187. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 188. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 189. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 193. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 194. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 195. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 196. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 200. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 201. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 202. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 203. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 208. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 209. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 210. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 215. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 216. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 217. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 221. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 222. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 223. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 224. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 229. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 230. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 231. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 235. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 236. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 237. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 238. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 242. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 243. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 244. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 245. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 249. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 250. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 251. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 252. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 256. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 257. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 258. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 259. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 263. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 264. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 265. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 266. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 270. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 271. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 277. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 278. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 279. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 280. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 284. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 285. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 286. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 287. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 291. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 292. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 293. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 294. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 298. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 299. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 300. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 301. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 305. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 306. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 307. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 308. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED KINGDOM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED KINGDOM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED KINGDOM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 315. UNI